• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个性化产前基因组检测:夫妇在染色体微阵列分析中对不确定和成人发病的发现做出选择的体验。

Personalized prenatal genomic testing: Couples' experience with choice regarding uncertain and adult-onset findings from chromosomal-microarray-analysis.

机构信息

Genetics Department, Hadassah Medical Center, Jerusalem, Israel.

Faculty of Medicine, Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Israel.

出版信息

Prenat Diagn. 2021 Feb;41(3):376-383. doi: 10.1002/pd.5856. Epub 2020 Nov 12.

DOI:10.1002/pd.5856
PMID:33128404
Abstract

BACKGROUND

Chromosomal-microarray-analysis (CMA) can identify variants of uncertain clinical significance, susceptibility-loci for neurodevelopmental conditions, and risk for adult-onset conditions. We explored choices made by couples undergoing prenatal CMA, their understanding of these findings, reasons for and against receiving them, and whether they believe parents or professionals should decide which are disclosed.

METHODS

Semi-structured interviews were conducted with women (n = 27) or their partners (n = 15) during the week following prenatal CMA testing and analyzed using grounded theory.

RESULTS

Over half the interviewees (55%) recalled at least two of the three types of CMA results they chose whether to receive. Sixty-four percent found the choice simple, whereas 36% found it difficult. All participants could clearly explain their choices, which were based on the perceived actionability and psychological impact of the information. Sixty percent viewed their choice favorably, whereas ~21% would have preferred clinicians to decide for them. More women than men, and more decisive than indecisive participants supported parental choice.

CONCLUSION

Overall, expectant parents can make informed choices about which uncertain findings about their fetuses they wish to receive, and value the opportunity to tailor results to their values and wishes. Arguments presented provide the basis for a decision-aid tool for expecting parents.

摘要

背景

染色体微阵列分析(CMA)可以识别临床意义不确定的变异、神经发育疾病的易感基因座,以及成年发病疾病的风险。我们探讨了接受产前 CMA 的夫妇所做的选择、他们对这些发现的理解、接受或拒绝的原因,以及他们是否认为应该由父母还是专业人员来决定披露哪些发现。

方法

在产前 CMA 检测后的一周内,对 27 名女性(n=27)或其伴侣(n=15)进行了半结构化访谈,并使用扎根理论进行了分析。

结果

超过一半的受访者(55%)至少回忆起他们选择接受的三种 CMA 结果中的两种。64%的人认为选择很简单,而 36%的人认为选择很困难。所有参与者都能清楚地解释他们的选择,这些选择基于信息的可操作性和心理影响。60%的参与者对自己的选择表示满意,而~21%的参与者希望由临床医生为他们做出决定。更多的女性而非男性,以及更果断的参与者支持父母的选择。

结论

总的来说,准父母可以就他们希望接受哪些关于胎儿的不确定发现做出明智的选择,并重视有机会根据自己的价值观和愿望定制结果。提出的论点为预期父母提供了一个决策辅助工具的基础。

相似文献

1
Personalized prenatal genomic testing: Couples' experience with choice regarding uncertain and adult-onset findings from chromosomal-microarray-analysis.个性化产前基因组检测:夫妇在染色体微阵列分析中对不确定和成人发病的发现做出选择的体验。
Prenat Diagn. 2021 Feb;41(3):376-383. doi: 10.1002/pd.5856. Epub 2020 Nov 12.
2
Information Women Choose to Receive About Prenatal Chromosomal Microarray Analysis.信息女性选择接受关于产前染色体微阵列分析。
Obstet Gynecol. 2020 Jan;135(1):149-157. doi: 10.1097/AOG.0000000000003610.
3
Dilemmas in genetic counseling for low-penetrance neuro-susceptibility loci detected on prenatal chromosomal microarray analysis.产前染色体微阵列分析检测到低外显率神经易感性基因座的遗传咨询困境。
Am J Obstet Gynecol. 2018 Feb;218(2):247.e1-247.e12. doi: 10.1016/j.ajog.2017.11.559. Epub 2017 Nov 14.
4
"Something Extra on Chromosome 5": Parents' Understanding of Positive Prenatal Chromosomal Microarray Analysis (CMA) Results.5号染色体上的额外发现:父母对产前染色体微阵列分析(CMA)阳性结果的理解
J Genet Couns. 2016 Oct;25(5):1116-26. doi: 10.1007/s10897-016-9943-z. Epub 2016 Mar 4.
5
"It's probably nothing, but…" Couples' experiences of pregnancy following an uncertain prenatal genetic result.“可能没什么,但……”夫妇在产前遗传结果不确定的情况下怀孕的经历。
Acta Obstet Gynecol Scand. 2020 Jun;99(6):791-801. doi: 10.1111/aogs.13813. Epub 2020 Feb 5.
6
Receiving uncertain results from prenatal chromosomal microarray analysis: Women's decisions on continuation or termination of pregnancy.从产前染色体微阵列分析中获得不确定的结果:女性对继续或终止妊娠的决定。
Prenat Diagn. 2023 Jun;43(6):773-780. doi: 10.1002/pd.6337. Epub 2023 Mar 7.
7
Clinicians' attitudes towards parental choice in the era of advanced genomic tests in pregnancy.临床医生在孕期先进基因组检测时代对父母选择的态度。
Prenat Diagn. 2021 Aug;41(9):1066-1073. doi: 10.1002/pd.6010. Epub 2021 Jul 19.
8
An exploration of genetic counselors' needs and experiences with prenatal chromosomal microarray testing.对遗传咨询师在产前染色体微阵列检测方面的需求和经验的探索。
J Genet Couns. 2014 Dec;23(6):938-47. doi: 10.1007/s10897-014-9702-y. Epub 2014 Feb 27.
9
Parents' Perspectives on Variants of Uncertain Significance from Chromosome Microarray Analysis.父母对染色体微阵列分析中意义未明变异的看法。
J Genet Couns. 2016 Feb;25(1):101-11. doi: 10.1007/s10897-015-9847-3. Epub 2015 May 19.
10
Informed Decision-Making in the Context of Prenatal Chromosomal Microarray.产前染色体微阵列背景下的知情决策
J Genet Couns. 2018 Sep;27(5):1130-1147. doi: 10.1007/s10897-018-0231-y. Epub 2018 Mar 7.

引用本文的文献

1
Postpartum women's attitudes to disclosure of adult-onset conditions in pregnancy.产后妇女对妊娠中成年发病情况披露的态度。
Prenat Diagn. 2022 Jul;42(8):1038-1048. doi: 10.1002/pd.6162. Epub 2022 May 4.
2
Molecular Approaches in Fetal Malformations, Dynamic Anomalies and Soft Markers: Diagnostic Rates and Challenges-Systematic Review of the Literature and Meta-Analysis.胎儿畸形、动态异常和软指标的分子检测方法:诊断率与挑战——文献系统综述与荟萃分析
Diagnostics (Basel). 2022 Feb 23;12(3):575. doi: 10.3390/diagnostics12030575.
3
Views of Israeli healthcare professionals regarding communication of genetic variants of uncertain significance to patients.
以色列医疗保健专业人员对向患者传达意义不明的遗传变异体的看法。
J Genet Couns. 2022 Aug;31(4):912-921. doi: 10.1002/jgc4.1560. Epub 2022 Feb 4.
4
Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification.责任分散:以色列医疗保健人员对变异重新分类后患者重新联系的看法
J Community Genet. 2022 Feb;13(1):13-18. doi: 10.1007/s12687-021-00556-x. Epub 2021 Oct 5.